Overview:

Regular visits with a primary care provider are important for maintaining quality health. By visiting the GoGetDoc website, Kansans have another option to assist them. Patients with a positive COVID-19 test and mild to moderate symptoms of COVID-19 will meet virtually with a Kansas doctor to discuss treatment options, including Paxlovid and Lagevrio.

People of color – especially Black and Hispanic people – were less likely to receive Paxlovid and other Covid-19 treatments, according to a study published late last month by the U.S. Centers for Disease Control and Prevention.

Throughout the pandemic, Black and Hispanic people have been about two times more likely than White people to be hospitalized or die from Covid-19.

The new study showed Black Covid-19 patients were 36% less likely than White patients to be treated with Paxlovid, and Hispanic patients were 30% less likely than non-Hispanic patients to receive the antiviral pill.

Nearly one in three White patients were prescribed Paxlovid, compared with about one in five Black and Hispanic patients and about one in four Asian and American Indian patients.

Racial and ethnic disparities persisted within the group of immunocompromised patients and across all age groups. The largest difference was between Black and White patients age 65 to 79, where White patients were 44% more likely to receive a Paxlovid prescription.

There were also disparities in other treatments – including molnupiravir, remdesivir and bebtelovimab – but treatments were much less frequently prescribed overall.

Reasons for the disparities were not directly assessed in this study, but the researchers suggest multiple contributing factors, including disparities to access to treatment facilities.

Paxlovid can reduce risk of hospitalization or death, but it works best when used within a few days of symptoms beginning. It requires a prescription, and it’s harder for some people to reach a health care provider in a timely manner. The researchers also note the possible implications of racism or implicit bias among providers and patient distrust of the medical system based on prior negative experiences.

Racial and ethnic disparities in Covid-19 vaccination rates have improved, but less than half (44%) of the Black population has completed their initial series – below the national average of 68% and less than any other racial and ethnic group, according to CDC data.

New KDHE Simplifies Access to COVID-19 Antiviral Prescriptions

The Kansas Department of Health and Environment (KDHE) is collaborating with GoGetDoc to simplify access to COVID-19 antiviral prescriptions. GoGetDoc is offering reduced-price telehealth visits for those with a positive COVID-19 test in an effort to make oral antiviral treatment (Paxlovid and Lagevrio) more accessible to vulnerable communities. Kansans can now visit the GoGetDoc website to complete an initial screening to see if they are eligible.

Regular visits with a primary care provider are important for maintaining quality health. By visiting the GoGetDoc website, Kansans have another option to assist them. Patients with a positive COVID-19 test and mild to moderate symptoms of COVID-19 will meet virtually with a Kansas doctor to discuss treatment options, including Paxlovid and Lagevrio.

Oral antiviral therapy for COVID-19 is authorized for people ages 12 and older who weigh more than 88 pounds.

Kansans who need more support may email support@gogetdoc.com with questions.